melanoma care: continued progress with immunotherapy in resectable and unresectable disease
Published 3 years ago • 291 plays • Length 1:05:54Download video MP4
Download video MP3
Similar videos
-
1:04:52
harnessing the power of immunotherapy in resectable melanoma
-
1:20:31
choosing innovation with immunotherapy in melanoma
-
54:59
linking immunotherapy to better outcomes in resectable melanoma
-
1:02:49
resectable melanoma: immune checkpoint inhibitors as adjuvant and neoadjuvant therapy
-
1:26:11
immunotherapy for the win against melanoma
-
1:09:01
resectable melanoma: perspectives on using immune-based adjuvant and neoadjuvant therapy
-
1:23:36
collaborative care and next steps with adjuvant and neoadjuvant immunotherapy for melanoma
-
1:07:38
drs. wargo, ariyan, & postow discuss #melanoma at #sso2023 - https://bit.ly/40kl2pl
-
1:01:29
new rules for sequential care in braf-mutated melanoma
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
1:09
progress in treatment approaches for patients with melanoma
-
1:31:16
pathologic response after neoadjuvant immunotherapy: facilitating progress in early-stage cancers
-
1:04:49
navigating multidisciplinary care with immunotherapy in esophageal/gej cancer
-
23:27
immunotherapy with high dose interleukin 2: role in the era of yervoy and zelboraf
-
43:46
realizing the promise of perioperative immunotherapy in resectable nsclc
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
52:47
complications of immunotherapy in oncology, 12/2/20
-
10:35
measuring response to immunotherapy in melanoma